• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于秀丽隐杆线虫生物活性和靶点鉴定的小分子高通量筛选。

High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.

作者信息

Burns Andrew R, Kwok Trevor C Y, Howard Al, Houston Ed, Johanson Karl, Chan Anthony, Cutler Sean R, McCourt Peter, Roy Peter J

机构信息

Department of Medical Genetics and Microbiology, The Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, M5S 1A8, Canada.

出版信息

Nat Protoc. 2006;1(4):1906-14. doi: 10.1038/nprot.2006.283.

DOI:10.1038/nprot.2006.283
PMID:17487175
Abstract

This protocol describes a procedure for screening small molecules for bioactivity and a genetic approach to target identification using the nematode Caenorhabditis elegans as a model system. Libraries of small molecules are screened in 24-well plates that contain a solid agar substrate. On top of the agar mixture, one small-molecule species is deposited into each well, along with worm food (E. coli), and two third-stage or fourth-stage larval worms using a COPAS (Complex Object Parametric Analyzer and Sorter) Biosort. Three to five days later the plates are screened for phenotype. Images of the wells are acquired and archived using a HiDI 2100 automated imaging system (Elegenics). Up to 2,400 chemicals can be screened per week. To identify the predicted protein target of a bioactive molecule, wild-type worms are mutagenized using ethylmethanesulfonate (EMS). Progeny are screened for individuals resistant to the molecules effects. The candidate mutant target that confers resistance is then identified. Target identification might take months.

摘要

本方案描述了一种筛选具有生物活性的小分子的程序以及一种利用线虫秀丽隐杆线虫作为模型系统进行靶点鉴定的遗传学方法。小分子文库在含有固体琼脂底物的24孔板中进行筛选。在琼脂混合物之上,使用COPAS(复杂物体参数分析仪和分选仪)生物分选仪将一种小分子物质与蠕虫食物(大肠杆菌)以及两条第三阶段或第四阶段的幼虫放入每个孔中。三到五天后,对平板进行表型筛选。使用HiDI 2100自动成像系统(Elegenics)获取并存档孔的图像。每周最多可筛选2400种化学物质。为了鉴定生物活性分子的预测蛋白质靶点,使用甲基磺酸乙酯(EMS)对野生型蠕虫进行诱变。筛选后代中对该分子效应具有抗性的个体。然后鉴定赋予抗性的候选突变靶点。靶点鉴定可能需要数月时间。

相似文献

1
High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.用于秀丽隐杆线虫生物活性和靶点鉴定的小分子高通量筛选。
Nat Protoc. 2006;1(4):1906-14. doi: 10.1038/nprot.2006.283.
2
A small-molecule screen in C. elegans yields a new calcium channel antagonist.在秀丽隐杆线虫中进行的小分子筛选产生了一种新的钙通道拮抗剂。
Nature. 2006 May 4;441(7089):91-5. doi: 10.1038/nature04657.
3
Caenorhabditis elegans: a versatile platform for drug discovery.秀丽隐杆线虫:药物发现的多功能平台。
Biotechnol J. 2006 Dec;1(12):1405-18. doi: 10.1002/biot.200600176.
4
Drug discovery: here comes the worm.药物研发:线虫登场了。
ACS Chem Biol. 2006 Jun 20;1(5):277-8. doi: 10.1021/cb600221m.
5
RNAi screens in Caenorhabditis elegans in a 96-well liquid format and their application to the systematic identification of genetic interactions.以96孔液体形式在秀丽隐杆线虫中进行的RNA干扰筛选及其在遗传相互作用系统鉴定中的应用。
Nat Protoc. 2006;1(3):1617-20. doi: 10.1038/nprot.2006.245.
6
Caenorhabditis elegans gcs-1 confers resistance to arsenic-induced oxidative stress.秀丽隐杆线虫的gcs-1基因赋予其对砷诱导的氧化应激的抗性。
Biometals. 2005 Oct;18(5):519-28. doi: 10.1007/s10534-005-2996-3.
7
Efficient target-selected mutagenesis in Caenorhabditis elegans: toward a knockout for every gene.秀丽隐杆线虫中高效的靶向选择诱变:实现每个基因的敲除
Genome Res. 2007 May;17(5):649-58. doi: 10.1101/gr.6080607. Epub 2007 Apr 6.
8
Endocrine targets for pharmacological intervention in aging in Caenorhabditis elegans.秀丽隐杆线虫衰老过程中药物干预的内分泌靶点。
Aging Cell. 2006 Feb;5(1):23-30. doi: 10.1111/j.1474-9726.2006.00186.x.
9
Isolation of Caenorhabditis elegans gene knockouts by PCR screening of chemically mutagenized libraries.通过对化学诱变文库进行PCR筛选分离秀丽隐杆线虫基因敲除体。
Nat Protoc. 2006;1(5):2231-40. doi: 10.1038/nprot.2006.345.
10
Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.秀丽隐杆线虫作为研究神经肌肉疾病的化学筛选工具。手动和半自动方法。
Methods. 2012 Jan;56(1):103-13. doi: 10.1016/j.ymeth.2011.10.010. Epub 2011 Oct 21.

引用本文的文献

1
Drug screens using the nematode Caenorhabditis elegans.使用线虫秀丽隐杆线虫进行药物筛选。
Genetics. 2025 Sep 3;231(1). doi: 10.1093/genetics/iyaf141.
2
Anti-Aging Effects and Mechanisms of Cod Collagen Peptides (CCPs) in .鳕鱼胶原蛋白肽(CCPs)的抗衰老作用及机制
J Funct Biomater. 2025 Apr 23;16(5):150. doi: 10.3390/jfb16050150.
3
Advances in Anthelmintic Target Identification.抗寄生虫药物靶点鉴定的进展
Int J Mol Sci. 2025 Apr 15;26(8):3738. doi: 10.3390/ijms26083738.
4
A new class of natural anthelmintics targeting lipid metabolism.一类针对脂质代谢的新型天然驱虫药。
Nat Commun. 2025 Jan 2;16(1):305. doi: 10.1038/s41467-024-54965-w.
5
Cyprocide selectively kills nematodes via cytochrome P450 bioactivation.西普罗赛德通过细胞色素 P450 生物激活选择性杀死线虫。
Nat Commun. 2024 Jul 2;15(1):5529. doi: 10.1038/s41467-024-49738-4.
6
A phenotypic screen of the Global Health Priority Box identifies an insecticide with anthelmintic activity.全球卫生重点药物清单表型筛选发现一种具有驱虫活性的杀虫剂。
Parasit Vectors. 2024 Mar 14;17(1):131. doi: 10.1186/s13071-024-06183-y.
7
Genetic and physical interactions reveal overlapping and distinct contributions to meiotic double-strand break formation in .遗传和物理相互作用揭示了对减数分裂双链断裂形成的重叠且独特的贡献。
bioRxiv. 2024 May 30:2024.02.23.581796. doi: 10.1101/2024.02.23.581796.
8
Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans.鉴定秀丽隐杆线虫中 BSCL2 脂肪营养不良致病变体的遗传抑制因子。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050524. Epub 2024 Apr 16.
9
PGP-14 establishes a polar lipid permeability barrier within the C. elegans pharyngeal cuticle.PGP-14 在秀丽隐杆线虫的咽表皮内建立了一个极性脂通透性屏障。
PLoS Genet. 2023 Nov 6;19(11):e1011008. doi: 10.1371/journal.pgen.1011008. eCollection 2023 Nov.
10
as an In Vivo Model for the Discovery and Development of Natural Plant-Based Antimicrobial Compounds.作为天然植物源抗菌化合物发现与开发的体内模型。
Pharmaceuticals (Basel). 2023 Jul 27;16(8):1070. doi: 10.3390/ph16081070.